The American Diabetes Association's Shift from Courage to Controversy
The American Diabetes Association, once praised for its bravery, now faces criticism for its handling of dissent within the medical community.
Financial news, markets, and business updates
The American Diabetes Association, once praised for its bravery, now faces criticism for its handling of dissent within the medical community.
In San Diego, a surge in syphilis cases highlights the challenges researchers face amid a drug shortage and complex patient interactions.
Capricor Therapeutics faces skepticism over its Duchenne MD therapy data, while the biotech sector grapples with leadership turmoil and FDA scrutiny.
A recent FDA panel's critical vote against a Duchenne drug highlights ongoing scrutiny of digital health practices, particularly Hims & Hers.
Latigo Biotherapeutics' LTG-001 demonstrates significant pain relief in Phase 2 trials, marking a potential shift in non-opioid pain management options.
The FTC has initiated a lawsuit against Hims & Hers, accusing the telehealth firm of deceptive practices in consumer health data handling.
The end of Medicare drug subsidies is set to elevate out-of-pocket costs for older adults, providing Democrats with a potent campaign issue for the midterms.
A fugitive assumed a new life in biotech, while a New Hampshire hospital challenges Eli Lilly's controversial pricing policies under the 340B program.
A recent study reveals clinical AI models underperform compared to generalist models, sparking debate in the health AI community.
The revelation of a fugitive's secret biotech career sparks scrutiny over hiring practices and vetting processes in the industry.
Despite a horror renaissance, space horror films have faded from Hollywood. Explore why the genre isn't taking off again on the cinematic stage.
In an exclusive interview, astronaut Michael Foale shares his experiences during the 1997 Mir space station collision and the challenges that followed.
Explore the legacy of Viking 1's Mars landing as experts discuss its findings and the latest developments in space exploration.
The recent Cyclospora outbreak highlights the urgent need for improved food safety measures to protect public health while promoting nutritious diets.
A tragic incident involving a six-year-old girl’s death from experimental CRISPR therapy in China has sparked urgent ethical discussions in biotech.
An FDA advisory panel endorses peptide accessibility, while Sanofi's insulin pen faces supply shortages, impacting diabetes patients nationwide.
Merck has signed licensing agreements with seven companies to produce and distribute a generic version of its experimental HIV prevention pill in 129 countries.
As medical students face new federal loan caps, the barrier to entry in medicine is rising, threatening diversity and access in the healthcare workforce.
A new outbreak of cyclospora, a parasite causing intestinal illness, has been reported with 72 cases identified; investigations are ongoing.
The European Medicines Agency is swiftly advancing clinical trial transparency, responding to concerns over low reporting compliance in a key database.